Verition Fund Management
LEGN icon

Verition Fund Management’s Legend Biotech LEGN Stock Holding History

Verition Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,274
Closed -$1.18M – 2994
2025
Q4 		$1.18M Buy
+54,274
New +$1.55M ﹤0.01% 2032
2025
Q1 		– Sell
-7,826
Closed -$255K – 3529
2024
Q4 		$255K Buy
+7,826
New +$324K ﹤0.01% 2855

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Verition Fund Management's LEGN Position: Q1 2026 in Review

Verition Fund Management sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 54,274 shares — an estimated $1.18M sold.

Verition Fund Management first reported a position in LEGN in Q4 2024 and held it in 2 quarters. The position peaked at $1.18M in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Verition Fund Management reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 54,274 Legend Biotech shares in Q1 2026, an estimated $1.18M.
  • Verition Fund Management first reported a position in Legend Biotech in Q4 2024 and held it in 2 quarters.
  • Verition Fund Management's Legend Biotech position peaked at $1.18M in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.